Wardha: Amid a huge shortage of vaccines in several states for carrying out the vaccination drive to combat the COVID-19 surge, the Centre has decided to increase the production of anti-viral drug Remdesivir.


COMMERCIAL BREAK
SCROLL TO CONTINUE READING

This was announced by Union Minister Nitin Gadkari on Thursday. The Minister said that the Remdesivir drug will be provided to people at a reasonable price fixed by the government.


The announcement came after several cases of black marketing of Remdesivir came to light amid the COVID-19 spike in the country.


 



 


"There was a shortage of Remdesivir injection. Because of this, incidents of black marketing took place, several people lost their lives as they have not received Remdesivir, so we decided to increase its production," Gadkari said.


"But we tried (and to got manufacturing rights), Remdesivir will be provided to people at government`s price. Now, I think there will be no black marketing or no person will die due to lack of it, there is no reservation, can be provided to other states when there will be surplus," he added.


Gadkari had on Thursday visited the Genetic Life Sciences (pharmacy) in Wardha to oversee the production of Remdesivir injections.


 



 


There are currently 35,66,398 active cases in the country, as per Union Health Ministry. 


America’s top public health expert Dr. Anthony Fauci termed India’s current COVID-19 situation ‘very desperate’ and ‘urgent’, adding that the government authorities need to allocate all of their resources, including armed forces, to immediately construct makeshift hospitals for the people.


Live TV